Itorex

Cefuroxime sodium, the active ingredient in Itorex, is a second‑generation cephalosporin presented as an injectable solution for intramuscular use. It treats a range of bacterial infections in adults and children as prescribed by a healthcare professional.

GNH USA supplies Itorex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Cefuroxime sodium is a broad‑spectrum cephalosporin antibiotic used to treat infections of the respiratory, urinary, and skin systems.

- Community‑acquired pneumonia: eliminates causative bacteria and improves respiratory symptoms. - Upper and lower respiratory tract infections: reduces bacterial load and accelerates recovery. - Urinary tract infections: eradicates common uropathogens and relieves urinary symptoms. - Skin and soft‑tissue infections: clears bacterial invasion of skin layers. - Acute otitis media: resolves middle‑ear infection and associated pain. - Sinusitis: treats bacterial sinus inflammation and restores normal drainage.

Cefuroxime sodium may cause a range of adverse reactions, most of which are mild and self‑limiting.

Common Side Effects: - Injection site pain: mild discomfort at the intramuscular site. - Diarrhoea: loose stools occurring during therapy. - Nausea: feeling of queasiness without vomiting. - Vomiting: expulsion of stomach contents. - Rash: mild skin redness or itching. - Transient elevation of liver enzymes: temporary increase in hepatic markers.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with breathing difficulty. - Clostridioides difficile‑associated diarrhoea: severe colitis after antibiotic use. - Stevens‑Johnson syndrome: rare, life‑threatening skin reaction. - Hemolytic anemia: destruction of red blood cells. - Thrombocytopenia: low platelet count increasing bleeding risk. - Acute renal impairment: sudden decrease in kidney function.

Before using Itorex, clinicians should consider several safety measures.

- Assess allergy: verify no known hypersensitivity to cephalosporins or penicillins. - Evaluate renal function: adjust dose in patients with impaired kidney function. - Monitor hepatic enzymes: watch for significant liver enzyme elevations. - Caution in pregnancy: use only if the potential benefit outweighs risk. - Observe for superinfection: discontinue if signs of secondary infection appear. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Cefuroxime sodium can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Probenecid: may increase cefuroxime plasma levels and risk toxicity. - Live bacterial vaccines: antibiotic may diminish vaccine effectiveness. - Warfarin: potential enhancement of anticoagulant effect leading to bleeding.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxic potential; monitor renal function. - Loop diuretics: may increase risk of renal impairment. - Oral contraceptives: possible reduction in contraceptive efficacy; advise alternative protection.